Holen Sie sich die Stockscreener-App
6.14
1.60%
-0.10
Vorhandelsmarkt:
6.02
-0.12
-1.95%
Schlusskurs vom Vortag:
$6.24
Offen:
$6.2
24-Stunden-Volumen:
2.78M
Relative Volume:
0.77
Marktkapitalisierung:
$941.42M
Einnahmen:
$418.84M
Nettoeinkommen (Verlust:
$-1.60M
KGV:
-596.12
EPS:
-0.0103
Netto-Cashflow:
$69.77M
1W Leistung:
-0.97%
1M Leistung:
+6.78%
6M Leistung:
-49.38%
1J Leistung:
-55.28%
1-Tages-Spanne:
$6.12
$6.28
1-Wochen-Bereich:
$5.875
$6.48
52-Wochen-Spanne:
$5.19
$14.04
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
6.14 | 941.42M | 418.84M | -1.60M | 69.77M | -0.0103 |
VEEV
Veeva Systems Inc
|
158.49 | 25.89B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
47.49 | 9.17B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
51.10 | 9.17B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
81.18 | 6.86B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
25.23 | 4.84B | 1.10B | 112.09M | 283.19M | 0.6096 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-02-27 | Herabstufung | Craig Hallum | Buy → Hold |
| 2026-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-11-21 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-29 | Eingeleitet | Craig Hallum | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Hochstufung | UBS | Neutral → Buy |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
Certara (CERT) price target decreased by 23.74% to 9.63 - MSN
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates - MSN
Certara to sell regulatory and medical writing business for up to $135M - MSN
How The Certara (CERT) Story Is Shifting As Analysts Recut Targets And Expectations - Yahoo Finance
Certara strategic business divestiture comes at right time, says analyst - MSN
Wall Street analysts think Certara (CERT) could surge 43.28%: Read this before placing a bet - MSN
Certara: An Interesting Situation To Keep Track Off (NASDAQ:CERT) - Seeking Alpha
CERT Price Today: Certara, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
(CERT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm
Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? - MSN
CERT Certara posts 8.8 percent year-over-year Q4 2025 revenue growth despite sizeable EPS miss pressuring shares.Barrier to Entry - UBND thành phố Hải Phòng
Certara to Divest Regulatory and Medical Writing Business - The Globe and Mail
Certara to sell regulatory writing unit to Veristat for $135M By Investing.com - Investing.com India
Is Certara (CERT) stock considered stable (+2.26%) 2026-04-22Price Surge - Cổng thông tin điện tử tỉnh Lào Cai
Certara (CERT) Sells Regulatory Writing Business for Up to $135 Million - GuruFocus
Veristat to Acquire Certara’s Regulatory and Medical Writing Business - Business Wire
Veristat, LLC signed a definitive agreement to acquire Regulatory and Medical Writing business of Certara, Inc for approximately $140 million. - marketscreener.com
Certara to Sell Regulatory and Medical Writing Business to Veristat for Up to $135 Million, Refocuses on Model-Informed Drug Development 1 - Minichart
Certara to sell regulatory writing unit to Veristat for $135M - Investing.com
Certara to Sell Regulatory, Medical Writing Business to Veristat for $135 Million - marketscreener.com
Certara : Regulatory and Medical Writing – Supplemental Information - marketscreener.com
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat - The Manila Times
Certara to Sell Global Medical Writing Business to Veristat for $100M, Plus Up to $35M Earn-Out - TradingView
Certara (NASDAQ: CERT) divests regulatory and medical writing unit to Veristat - Stock Titan
Certara, Inc. $CERT Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Why Certara (CERT) Stock Is Rising Now (Investor Interest) 2026-04-16Pro Trader Recommendations - Cổng thông tin điện tử Tỉnh Sơn La
Certara Inc stock (US1567671046): Why does its biosimulation edge matter more now for drug developme - AD HOC NEWS
Liquidity Mapping Around (CERT) Price Events - Stock Traders Daily
CERT Maintained by Keybanc -- Price Target Lowered to $8.00 - GuruFocus
Portfolio Update: How do insiders feel about Certara Inc2026 Stock Rankings & AI Forecasted Entry and Exit Points - baoquankhu1.vn
KeyBanc Maintains Certara(CERT.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
Certara (NASDAQ:CERT) Price Target Cut to $8.00 by Analysts at KeyCorp - MarketBeat
Bioequivalence Studies Simulators Market is expected to Hit US$ - openPR.com
Craig-Hallum Maintains Certara(CERT.US) With Hold Rating - Moomoo
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 - The Manila Times
Certara sets May 11 earnings release, webcast starts at 8:30 ET - Stock Titan
If You Invested $1,000 in Certara, Inc. (CERT) - Stock Titan
How The Certara (CERT) Story Is Evolving As Price Targets Reset And Growth Plans Lag - Yahoo Finance
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.08%
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):